Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-second-quarter-2024-results-and-provides-corporate-update-302219948.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-completion-of-enrollment-of-phase-2-tailwind-study-of-inhaled-ap-pa02-in-non-cystic-fibrosis-bronchiectasis-subjects-with-chronic-pulmonary-pseudomonas-aeruginosa-infection-302194296.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-presentation-at-viruses-of-microbes-2024-302191113.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-first-quarter-2024-results-and-provides-corporate-update-302137803.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-fourth-quarter-and-full-year-2023-results-and-provides-corporate-update-302095250.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-35-million-secured-credit-agreement-with-innoviva-302078816.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-presentation-at-the-6th-annual-bacteriophage-therapy-summit-302066704.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-third-quarter-2023-results-and-provides-corporate-update-301988168.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-presentation-of-topline-data-from-swarm-pa-clinical-study-at-the-north-american-cystic-fibrosis-conference-301965126.html
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-first-patient-dosed-in-the-phase-2a-portion-of-the-phase-1b2a-disarm-study-of-ap-sa02-in-adults-with-bacteremia-due-to-staphylococcus-aureus-301937830.html